OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improving the Efficacy of Regulatory T Cell Therapy
Paulien Baeten, Lauren Van Zeebroeck, Markus Kleinewietfeld, et al.
Clinical Reviews in Allergy & Immunology (2021) Vol. 62, Iss. 2, pp. 363-381
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders – Advances and challenges
T. K. Goswami, Mithilesh Singh, Manish Dhawan, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 128

Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clinical Trials
Amir Vahedian‐Azimi, Mitra Abbasifard, Farshid Rahimi‐Bashar, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 256-256
Open Access | Times Cited: 115

Boosting regulatory T cell function for the treatment of autoimmune diseases – That’s only half the battle!
Janine Schlöder, Fatemeh Zare Shahneh, Franz-Joseph Schneider, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 38

Targeting tumor-infiltrating tregs for improved antitumor responses
Diyuan Qin, Yugu Zhang, Pei Shu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 14

Treg in inborn errors of immunity: gaps, knowns and future perspectives
Rebeca Kennedy-Batalla, Daniel Acevedo, Yiyi Luo, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 11

Regulating the regulatory T cells as cell therapies in autoimmunity and cancer
Hamed Hosseinalizadeh, Fatemeh Rabiee, Negar Eghbalifard, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 20

Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers
Janne Verreycken, Paulien Baeten, Bieke Broux
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 7
Open Access | Times Cited: 25

AhR activation promotes Treg cell generation by enhancing Lkb1‐mediated fatty acid oxidation via the Skp2/K63‐ubiquitination pathway
Qin Zhang, Yanrong Zhu, Changjun Lv, et al.
Immunology (2023) Vol. 169, Iss. 4, pp. 412-430
Closed Access | Times Cited: 14

T-regulatory cells for the treatment of autoimmune diseases
Marina Fisher, С. В. Сенников
Frontiers in Immunology (2025) Vol. 16
Open Access

Yerba Mate (Ilex paraguariensis) Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating Regulatory T Cell Function
Andrés A. Herrada, Francisca Rodríguez-Arriaza, Alexandra Olate‐Briones, et al.
Nutrients (2025) Vol. 17, Iss. 5, pp. 897-897
Open Access

TIM3-Mediated Differentiation of IL-10-Producing CD25+ B Cells by Expanded Regulatory T Cells
Rowa Y. Alhabbab, Daniela Mastronicola, Giovanna Lombardi, et al.
Research Square (Research Square) (2025)
Closed Access

Exploiting regulatory T cells (Tregs): Cutting-edge therapy for autoimmune diseases
Marwa Hassan, Mohamed Elzallat, Dina Mostafa Mohammed, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114624-114624
Open Access

Vps34 puts the ‘e’ in eTreg cells
Ruchi Saxena, You‐Wen He
PLoS Biology (2025) Vol. 23, Iss. 4, pp. e3003109-e3003109
Open Access

Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges
Mehrdad Hefazi, Sara Bolivar-Wagers, Bruce R. Blazar
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9676-9676
Open Access | Times Cited: 26

Immune modulation in transplant medicine: a comprehensive review of cell therapy applications and future directions
Leonard Knoedler, J. H. Dean, Fortunay Diatta, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3

Mechanism of Emodin in the Treatment of Rheumatoid Arthritis
Lianying Cheng, Jie Chen, Xiaofeng Rong
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 14

Norisoboldine induces the development of Treg cells by promoting fatty acid oxidation‐mediated H3K27 acetylation of Foxp3
Qin Zhang, Yulai Fang, Changjun Lv, et al.
The FASEB Journal (2022) Vol. 36, Iss. 4
Open Access | Times Cited: 11

Rapamycin rescues loss of function in blood-brain barrier–interacting Tregs
Paulien Baeten, Ibrahim Hamad, Cindy Hoeks, et al.
JCI Insight (2024) Vol. 9, Iss. 7
Open Access | Times Cited: 2

B-cell immune dysregulation with low soluble CD22 levels in refractory seronegative myasthenia gravis
Yuumi Okuzono, Shuuichi Miyakawa, Tatsuo Itou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Regulatory T cells in lung disease and transplantation
Peizhen Lao, Jingyi Chen, Long‐Qian Tang, et al.
Bioscience Reports (2023) Vol. 43, Iss. 10
Open Access | Times Cited: 5

Engineering of regulatory T cells by means of mRNA electroporation in a GMP-compliant manner
Ibo Janssens, Diana Campillo-Davó, Jasper Van den Bos, et al.
Cytotherapy (2022) Vol. 24, Iss. 6, pp. 659-672
Open Access | Times Cited: 8

Long noncoding RNA LINC01882 ameliorates aGVHD via skewing CD4+ T cell differentiation toward Treg cells
Yao Teng, Linghui Xia, Zhen‐Li Huang, et al.
AJP Cell Physiology (2022) Vol. 324, Iss. 2, pp. C395-C406
Closed Access | Times Cited: 5

Page 1 - Next Page

Scroll to top